指南与共识肾小球疾病

Mayo Clinic膜性肾病共识:基于抗原的新型分类建议

Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.
指南 / 共识 · Kidney Int · 2023-10-05

膜性肾病是由自身抗体结合特定靶抗原、免疫复合物沿肾小球基底膜上皮下沉积所致。已发现至少14种靶抗原,覆盖80%-90%的膜性肾病病例。Mayo Clinic共识提出两步分类法:先鉴定靶抗原,再搜寻潜在基础疾病或相关状况。

要点

  • 膜性肾病已发现至少14种靶抗原,覆盖80%-90%病例。
  • 共识提出两步分类:先鉴定靶抗原,再搜寻潜在基础疾病。
  • 抗原鉴定采用血清学、免疫荧光/免疫组化及/或质谱多步骤算法。

核心结论

  • 会议共识认为已到采用基于抗原的膜性肾病分类的时候,该途径可实现准确且特异的诊断,对患者管理和靶向治疗有重要意义。

研究设计与样本

  • Mayo Clinic膜性肾病共识报告,提出两步分类法:第一步尽可能鉴定靶抗原,第二步搜寻潜在基础疾病或相关状况。

主要发现

  • 已鉴定至少14种靶抗原,覆盖80%-90%的膜性肾病病例。
  • 许多与新型靶抗原相关的膜性肾病具有独特的临床和病理表型。

关键数值与推荐

  • 第一步靶抗原鉴定基于多步骤算法,联合血清学、肾活检组织免疫荧光或免疫组化染色和/或质谱方法。
  • 第二步搜寻潜在基础疾病或相关状况,在已知靶抗原可指导搜寻时尤为相关。
  • 会议承认所提议检测所需的资源和设备可能并非普遍可及。

临床怎么用

  • 采用基于抗原的分类以实现准确且特异的膜性肾病诊断,对患者管理和靶向治疗有重要意义。

局限性

  • 原文述所提议检测所需的资源和设备可能并非普遍可及。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Membranous nephropathy (MN) is a pattern of injury caused by autoantibodies binding to specific target antigens, with accumulation of immune complexes along the subepithelial region of glomerular basement membranes. The past 20 years have brought revolutionary advances in the understanding of MN, particularly via the discovery of novel target antigens and their respective autoantibodies. These discoveries have challenged the traditional classification of MN into primary and secondary forms. At least 14 target antigens have been identified, accounting for 80%-90% of cases of MN. Many of the forms of MN associated with these novel MN target antigens have distinctive clinical and pathologic phenotypes. The Mayo Clinic consensus report on MN proposes a 2-step classification of MN. The first step, when possible, is identification of the target antigen, based on a multistep algorithm and using a combination of serology, staining of the kidney biopsy tissue by immunofluorescence or immunohistochemistry, and/or mass spectrometry methodology. The second step is the search for a potential underlying disease or associated condition, which is particularly relevant when knowledge of the target antigen is available to direct it. The meeting acknowledges that the resources and equipment required to perform the proposed testing may not be generally available. However, the meeting consensus was that the time has come to adopt an antigen-based classification of MN because this approach will allow for accurate and specific MN diagnosis, with significant implications for patient management and targeted treatment.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Sethi S, Beck LH, Glassock RJ, et al. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int. 2023. PMID: 37795587. doi:10.1016/j.kint.2023.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。